ARS vs ARS With Arthrocentesis and PRP Injection in DDWR

计划入组 20 人 · 首次发布于 2025 年 8 月 11 日

Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares

计划入组 24 人 · 首次发布于 2022 年 8 月 11 日

M-ARS ACL Post-marketing Surveillance Study

计划入组 200 人 · 首次发布于 2020 年 7 月 8 日

ARS-02

ARS-15

ARS-10

ARS PHARMACEUTICALS

India

GI Innovation, Inc.

South Korea

GI NUTRIHEALTH PTY LTD

Australia

Feinstein Institutes to Explore Ghrelin for Radiation-Induced Gastrointestinal Syndrome with NIH Grant

Synedgen and BARDA Partner to Develop MIIST305 for Gastrointestinal Acute Radiation Syndrome

RedHill Biopharma Secures U.S. Patent for Opaganib Biomarker in COVID-19 Treatment